Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model

Abstract

Objective:

To establish that human adipocytes express functional glucose-dependent insulinotropic peptide (GIP) receptors and in particular the regulation of GIP receptor (GIPR) expression in the context of the dynamic process of adipocyte differentiation.

Design:

A combination of semiquantitative real-time PCR and measurement of GIP-stimulated cAMP accumulation was used to establish the expression and functional coupling of GIPRs during in vitro differentiation of human Simpson–Golabi–Behmel syndrome (SGBS) preadipocytes.

Results:

Semiquantitative real-time PCR revealed that GIPR expression was substantially increased by day 4 of differentiation, reaching a maximum around 6–8 days (200-fold increase above undifferentiated cells, n=2). We also analysed the expression of the adipocyte fatty acid binding protein (FABP4) to relate GIPR expression to a molecular differentiation marker of adipogenesis. FABP4 expression was barely detectable in undifferentiated cells. However, following exposure to adipogenic medium, FABP4 expression gradually increased, with a maximal expression level around 10 days (1 600 000-fold increase above undifferentiated cells, n=2). Thus, the increases in GIPR mRNA during adipogenesis occur earlier than FABP4, suggesting that it might represent a gene expressed early in terminal differentiation and thus plays a role in fat droplet formation. A unit of 1 μM GIP failed to raise intracellular cAMP levels above basal levels in undifferentiated cells (n=3). In stark contrast, the 9-day differentiated cells produced a robust concentration-dependent increase in cAMP accumulation following stimulation with GIP, with an EC50 value of 2.3 nM (n=3). The maximal response represented a 9–34-fold increase in cAMP accumulation above basal levels.

Conclusions:

This study demonstrates that GIPRs are expressed by human adipocytes, both GIPR mRNA and functional receptor expression being present in differentiated adipocytes but not in preadipocytes. Further investigation into the functional effects of GIP on differentiated SGBS cells could help towards understanding exactly how GIP regulates fat accumulation in human adipocytes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Gault VA, O'Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR . Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin. Diabetologia 2003; 46: 222–230.

    Article  CAS  Google Scholar 

  2. Ross SA, Dupre J . Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Diabetes 1978; 27: 327–333.

    Article  CAS  Google Scholar 

  3. Yip RG, Wolfe MM . GIP biology and fat metabolism. Life Sci 2000; 66: 91–103.

    Article  CAS  Google Scholar 

  4. Baggio LL, Drucker DJ . Biology of incretins: GLP-1 and GIP. Gasteroent 2007; 132: 2131–2157.

    Article  CAS  Google Scholar 

  5. Beck B, Max JP . Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat. Regul Pept 1983; 7: 3–8.

    Article  CAS  Google Scholar 

  6. Yip RG, Boylan MO, Kieffer TJ, Wolfe MM . Functional GIP receptors are present on adipocytes. Endocrinol 1998; 139: 4004–4007.

    Article  CAS  Google Scholar 

  7. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002; 8: 738–742.

    Article  CAS  Google Scholar 

  8. Kim S-J, Nian C, McIntosh CH . Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem 2007; 282: 8557–8567.

    Article  CAS  Google Scholar 

  9. Gault VA, O'Harte FP, Harriott P, Flatt PR . Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. Biochem Biophys Res Commun 2002; 290: 1420–1426.

    Article  CAS  Google Scholar 

  10. Gault VA, McClean PL, Cassidy RS, Irwin N, Flatt PR . Chemical GIP receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetology 2007; 50: 1752–1762.

    Article  CAS  Google Scholar 

  11. Irwin N, McClean PL, O'Harte FPM, Gault VA, Harriott P, Flatt PR . Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice. Diabetology 2007; 50: 1532–1540.

    Article  CAS  Google Scholar 

  12. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI . Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is a widely distributed in peripheral organs and the brain. Endocrionol 1993; 133: 2861–2870.

    Article  CAS  Google Scholar 

  13. Rudovich N, Kaiser S, Engeli S, Osterhoff M, Gogebakan O, Bluher M et al. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept 2007; 142: 138–145.

    Article  CAS  Google Scholar 

  14. McIntosh CHS, Bremsak I, Lynn FC, Gill R, Hinke SA, Gelling R et al. Glucose-dependent insulinotropic polypeptide stimulation of lypolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. Endorinol 1999; 140: 398–404.

    Article  CAS  Google Scholar 

  15. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obesity 2001; 25: 8–15.

    Article  CAS  Google Scholar 

  16. Korner A, Wabitsch M, Seidel B, Fischer-Posovszky P, Berthold A, Stumvoll M et al. Adiponectin expression in humans is dependant on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun 2005; 337: 540–550.

    Article  Google Scholar 

  17. Janderova L, McNeil M, Murrell AN, Mynatt RL, Smith SR . Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res 2003; 11: 65–74.

    Article  CAS  Google Scholar 

  18. Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001; 25: 402–408.

    Article  CAS  Google Scholar 

  19. Balmforth AJ, Yasunari K, Vaughan PFT, Ball SG . Characterization of dopamine and β-adrenergic recptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma. J Neurochem 1988; 51: 1510–1515.

    Article  CAS  Google Scholar 

  20. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM . Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 2001; 276: 34167–34174.

    Article  CAS  Google Scholar 

  21. Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ . Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 2006; 291: E1100–E1105.

    Article  CAS  Google Scholar 

  22. Chihara Y, Rakugi H, Ishikawa K, Ikushima M, Maekawa Y, Ohta J et al. Klotho protein promotes adipocyte differentiation. Endocrinol 2006; 147: 3835–3842.

    Article  CAS  Google Scholar 

  23. Alihaud G, Hauner H . Development of white adipose tissue. In: Bray G, Bouchard C, James WPT (eds). Handbook of Obesity. Marcel Dekker: New York, 1997, pp 359–378.

    Google Scholar 

  24. Avram MM, Avram AS, James WD . Subcutaneous fat in normal and diseased states. 3. Adipogenesis: From stem cell to fat cell. J Am Acad Dermatol 2007; 56: 472–492.

    Article  Google Scholar 

  25. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P . Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41–47.

    Article  CAS  Google Scholar 

  26. Smith AJ, Thompson BR, Sanders MA, Bernlohr DA . Interaction of the adipocyte fatty acid-binding protein with the hormone sensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem 2007; 282: 32424–32432.

    Article  CAS  Google Scholar 

  27. Kletzien RF, Foellmi LS, Harris PKW, Wyse BM, Clarke SD . Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by insulin-sensitizing agent. Mol Pharmacol 1992; 42: 558–562.

    CAS  PubMed  Google Scholar 

  28. Halvorsen Y-D, Bond A, Sen A, Franklin DM, Lea-Currie YR, Sujkowski D et al. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. Metabolism 2001; 50: 407–413.

    Article  CAS  Google Scholar 

  29. Sekiya I, Larson BL, Vuoristo JT, Cui J-G, Prockop DJ . Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res 2004; 19: 256–264.

    Article  CAS  Google Scholar 

  30. Gremlich S, Porret A, Hani EH, Cherif D, Vionnet D, Frogel P et al. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 1995; 44: 1202–1208.

    Article  CAS  Google Scholar 

  31. Almind K, Ambye L, Urhammer SA, Hansen T, Echwald SM, Holst JJ et al. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells. Diabetologia 1998; 41: 1194–1198.

    Article  CAS  Google Scholar 

  32. Gault VA, Hunter K, Irwin N, Green BD, Greer B, Harriot P et al. Characterisation and biological activity of Glu3 amino acid substituted GIP receptor antagonists. Arch Biochem and Biophys 2007; 461: 263–274.

    Article  CAS  Google Scholar 

  33. Hauner H, Glatting G, Kaminska D, Pfeiffer EF . Effcets of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab 1988; 32: 382–388.

    Article  Google Scholar 

  34. Knapper JM, Puddicombe SM, Morgan LM, Fletcher JM . Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagons-like peptide-1(7-36) amide on lipoprotein lipase activity in explants of rat adipose tissue. J Nutrition 1995; 125: 183–188.

    CAS  Google Scholar 

  35. Kim S-J, Nian C, McIntosh CH . Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem 2007; 282: 34139–34147.

    Article  CAS  Google Scholar 

  36. Nagaev I, Smith U . Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285: 561–564.

    Article  CAS  Google Scholar 

  37. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferation-activated receptor-ã action in humans. Diabetes 2001; 50: 2199–2202.

    Article  CAS  Google Scholar 

  38. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM . Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002; 10: 1–5.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

RE Weaver is the recipient of a BBSRC studentship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A J Balmforth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weaver, R., Donnelly, D., Wabitsch, M. et al. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model. Int J Obes 32, 1705–1711 (2008). https://doi.org/10.1038/ijo.2008.148

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2008.148

Keywords

This article is cited by

Search

Quick links